Hypertension, Resistant to Conventional Therapy Clinical Trial
Official title:
HYPERTENSIVE PATIENT ADHERENCE TO TREATMENT: THE USE OF THERAPEUTIC COMMUNICATION ASSOCIATED WITH TECHNOLOGY EDUCATIONAL IN HEALTH PROMOTION"
Verified date | October 2017 |
Source | University of Sao Paulo General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Few studies show the benefits of educational technologies a support for the control of chronic diseases. The approach known as 'embracement' adopts relational strategies or soft technologies which promote bonding and may impact therapy adherence and quality of life in hypertensive patients.Objectives:To assess the impact of the embracement approach on therapy adherence, quality of life, and the white coat effect in hypertensive outpatients followed in a specialized clinic. This approach may be associated or not with the use of educational technology in a virtual learning environment(VLE) for distance learning (DL) and with use the educational technology in Blended E-learning (E-BLENDED)
Status | Completed |
Enrollment | 57 |
Est. completion date | February 17, 2017 |
Est. primary completion date | April 25, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Have the medical diagnosis of arterial hypertension, 2. Have blood pressure levels equal or above 140 mmHg for systolic blood pressure (SBP), and equal or above 90 mmHg for diastolic blood pressure (DBP), 3. Must be able to swallow tablets and under drug treatment with antihypertensives, 4. Have digital accessibility through smart phones, tablets or notebooks and PCs. Exclusion Criteria: 1. Patients with important cognitive impairment will be considered excluded, that is, with poor understanding of simple questions, 2. Clinical diagnosis of Alzheimer's disease, or chorea diseases that lead to cognitive impairment such as senile dementia, 3. Diagnosis of insulin dependent diabetes. - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo General Hospital | Chao Lung Wen, Dante Marcelo Artiga Giorgi, Fernanda Marciano Consolim-Colombo, Heno Ferreira Lopes, Isabela Ribeiro Braga Fistarol, Ivonete Sanches Giacometti Kowalski, Jefferson Carlos de Oliveira, Luiz Aparecido Bortolotto, Margarida Vieira, Miriam Harume Tsunemi |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | measure blood arterial pressure | At the first nurse interview (day 0: randomization), a questionnaire was used to obtain information related to general data, habits, history of disease, other risk factors for cardiovascular disease, and prescribed medications. This questionnaire was used only to characterize the adherence behavior and the risk factors at the beginning the study, but was not used to evaluate modifications of behavior during the study. Body weight and height were measured. Three consecutive measurements of BP were taken after the patient had rested for 5 min in the supine position. | 4 months | |
Primary | Ambulatory Blood Pressure monitoring | Ambulatory BP monitoring was recorded at day ) in randomization and 120 days of follow-up for 24 h with a noninvasive ABPM (Space Labs 90207 monitor; Space Labs, Redmond, WA) with an appropriate-sized cuff. The monitor was placed on the nondominant arm and was set to take BP readings every 10 min during the day and every 20 min at nigh | 4 months | |
Primary | Pill count | count of the compliments dispensed by the pharmacy and count of the empty blisters delivered in the consultation | up to 4 months | |
Secondary | The brief version of the World Health Organization quality of life (WHOQOL-BREF) | Questinaire | 4 months | |
Secondary | The Duke University Religion Index (DUREL) for a brief measure of religiosity that can be included between religion and health outcomes. | the isntrument | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02385864 -
CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
Completed |
NCT01833429 -
Autonomic Dysfunction in Resistant Hypertension
|
N/A | |
Completed |
NCT02426099 -
Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
|
Phase 4 | |
Recruiting |
NCT02623036 -
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
|
Phase 1 | |
Completed |
NCT02587533 -
Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation
|
N/A | |
Recruiting |
NCT01863082 -
Resistant Hypertension and Physical Activity Performed in a Heated Pool
|
N/A | |
Terminated |
NCT03730519 -
UK Registry for Baroreflex Activation Therapy
|
N/A | |
Active, not recruiting |
NCT05017935 -
RADIANCE Continued Access Protocol
|
N/A | |
Completed |
NCT01520506 -
Rapid Renal Sympathetic Denervation for Resistant Hypertension
|
N/A | |
Active, not recruiting |
NCT02369081 -
Optimum Treatment for Drug-Resistant Hypertension
|
Phase 4 | |
Withdrawn |
NCT04542681 -
MANP in African Americans With Hypertension
|
Phase 1 | |
Completed |
NCT05395403 -
Use of Automated Office Blood Pressure Monitoring
|
N/A | |
Recruiting |
NCT02057783 -
Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
|
N/A | |
Completed |
NCT01630928 -
Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors
|
N/A | |
Completed |
NCT01848275 -
Full Length Versus Proximal Renal Arteries Ablation
|
N/A | |
Completed |
NCT01062763 -
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
|
Phase 3 | |
Completed |
NCT01834118 -
Reintervention-study After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
|
N/A | |
Active, not recruiting |
NCT01703780 -
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
|
N/A | |
Not yet recruiting |
NCT02042066 -
Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension
|
Phase 1 | |
Completed |
NCT02667912 -
Distal Renal Denervation
|
N/A |